Americas Gold and Silver Corporation's stock drops amid market conditions
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 3d ago
0mins
Should l Buy USAS?
Source: Fool
Americas Gold and Silver Corporation (USAS) saw a decline of 5.00% as it crossed below the 5-day SMA, reflecting a shift in market sentiment. Despite the recent surge of 43.36% to a new 52-week high, the stock's current drop is attributed to sector rotation, as the S&P 500 (SPY) is down 0.05% while the Nasdaq-100 (QQQ) shows a slight gain of 0.35%. This indicates that while mining stocks have been performing well recently, USAS is experiencing a pullback in the context of broader market movements.
The recent performance of USAS, which reached a peak price of $9.41 before closing at $9.29, highlights the volatility in the mining sector, particularly with rising precious metal prices. The company achieved a record silver production of 2.65 million ounces in 2025, showcasing its strong operational capabilities. However, the current market dynamics suggest that investors are reassessing their positions, leading to the stock's decline despite its strong fundamentals.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy USAS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on USAS
Wall Street analysts forecast USAS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for USAS is 5.91 USD with a low forecast of 4.90 USD and a high forecast of 6.84 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 6.570
Low
4.90
Averages
5.91
High
6.84
Current: 6.570
Low
4.90
Averages
5.91
High
6.84
About USAS
Americas Gold and Silver Corporation is a Canada-based precious metals mining company with multiple assets in North America. It owns and operates the Galena Complex, Cosala Operations, and the Relief Canyon mine. It also owns the San Felipe development project in Sonora, Mexico. The 100% owned Galena Complex is located in Idaho's Silver Valley. The 100%-owned Cosala Operations are located in the state of Sinaloa, Mexico and consist of about 67 mining concessions that cover approximately 19,385 hectares (ha). The Relief Canyon Mine is located in Pershing County, Nevada. The project encompasses an open pit mine and heap leach processing facility. Its landholdings cover over 25,000 acres, which include the Relief Canyon Mine asset and lands surrounding the mine in all directions. The San Felipe silver-zinc-lead project is located in Sonora, Mexico. It also owns Crescent Silver Mine, which is located over four miles southeast of Kellogg, Idaho, and consists of 10 acres of surface rights.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Americas Gold and Silver Corp. (USAS) Soars 43.36% to New 52-Week High
- Stock Surge: Americas Gold and Silver Corporation (USAS) surged 43.36% last week, reaching a new 52-week high, reflecting strong investor interest in mining stocks amid rising precious metal prices.
- Daily Performance: On Friday, USAS hit a peak price of $9.41 before closing at $9.29, up 9.55% from the previous day, indicating optimistic market expectations for its future performance.
- Silver Price Rally: With spot silver prices exceeding $103 and gold nearing $4,988—just $12 shy of $5,000—the overall rise in mining stocks has been significantly boosted.
- Production Milestone: In 2025, Americas Gold and Silver achieved a record silver production of 2.65 million ounces, a 52% increase, with its Cosala operations alone producing 1.19 million ounces, showcasing the company's robust production capabilities in a rising silver price environment.
See More
RUA GOLD Inc. Accelerates Development of New Zealand Gold-Antimony Project Targeting 300,000 Ounces Resource
- Accelerated Resource Development: RUA GOLD's latest drilling results at the Auld Creek project in New Zealand's Reefton Goldfield show 3.0m @ 21.27 g/t AuEq, successfully extending the deposit strike length by 250 meters to a total of 870 meters, with expectations to increase the resource to over 300,000 ounces, significantly enhancing the company's competitiveness in the global antimony market.
- Legislative Support: The company plans to leverage New Zealand's FAST TRACK legislation to expedite production permits for the Auld Creek project, aiming for approval within six months, which provides RUA GOLD with a strategic advantage in the global critical minerals supply chain.
- Strong Financial Position: With $14 million in cash on hand and a leadership team behind $11 billion in prior exits, RUA GOLD is well-positioned to ensure financial stability in resource development and market competition, effectively navigating market fluctuations.
- Optimistic Market Outlook: As global gold prices are projected to reach $5,055 per ounce by Q4 2026, RUA GOLD's projects will benefit from capital inflows into efficient platforms, driving the company's long-term growth potential in the gold and antimony sectors.
See More
Bright Minds Biosciences Launches $100 Million Public Offering
- Public Offering Impact: Bright Minds Biosciences Inc's announcement of a $100 million public offering led to a 2.3% drop in its pre-market share price to $91.03, reflecting market concerns over the new issuance and potentially impacting the company's short-term financing capabilities.
- Market Reaction: Following the public offering news, Bright Minds' stock price decline indicates cautious investor sentiment regarding the company's future prospects, which may lead to increased financing costs.
- Industry Dynamics: This offering has drawn attention within the biotech sector, particularly as investor acceptance of new issues diminishes in the current market environment, potentially affecting financing plans for other biotech firms.
- Competitive Pressure: The decline in Bright Minds' stock price coincides with fluctuations in shares of other companies like Cohen & Company and Gloo Holdings, highlighting overall market uncertainty in the biotech sector, which could undermine investor confidence across the industry.
See More
Sprott Silver Miners ETF Declines 2.3% with Americas Gold and Vizsla Silver Underperforming
- ETF Performance Decline: The Sprott Silver Miners & Physical Silver ETF fell approximately 2.3% in Wednesday afternoon trading, reflecting a weak sentiment towards silver mining stocks that could impact investor confidence.
- Individual Stock Weakness: Shares of Americas Gold and Silver dropped about 2.8%, while Vizsla Silver declined by approximately 1.6%, indicating the vulnerability of these companies in the current market environment, potentially leading to capital outflows.
- Market Trend Analysis: The overall decline of the ETF is linked to fluctuations in silver prices and investor risk aversion towards mining stocks, which may influence future investment decisions and capital allocation.
- Investor Focus: As silver mining stocks continue to struggle, investors may need to reassess their allocations within precious metal portfolios to mitigate potential market risks.
See More
Cybin Inc Launches $100 Million Equity Program, Shares Drop 6.6%
- Stock Decline: Cybin Inc's shares fell 6.6% to $8.00 in pre-market trading following the announcement of a $100 million at-the-market equity program with Cantor Fitzgerald, which may undermine investor confidence and complicate future fundraising efforts.
- Market Reaction: The drop in Cybin's stock price reflects investor concerns regarding the new financing plan, potentially impacting the company's capital operations and shareholder value moving forward.
- Industry Impact: Concurrently, other biotech firms like Corcept Therapeutics and NovaBay Pharmaceuticals also experienced stock declines, indicating a cautious sentiment across the biotech sector that could affect the overall fundraising environment.
- Investor Focus: The lukewarm market response to Cybin's financing initiative may prompt the company to reassess its capital structure and financing strategies to navigate current market challenges.
See More
Peter Schiff: Silver Mining Stocks Should Have Doubled in December
- Surge in Silver Prices: In December, silver prices surged by 35% to $76 per ounce, yet the Global X Silver Miners ETF only rose by 11%, indicating a significant disconnect that may lead investors to miss out on potential gains.
- Investor Denial: Schiff highlighted that silver mining stocks typically offer leveraged exposure to silver prices, but their underperformance amid a strong rally reflects a skeptical market attitude towards the sustainability of silver price increases.
- Attractive Investment Opportunity: Despite a 14% correction in silver prices, Schiff suggests that silver mining stocks are now better buys, potentially attracting investors looking to capitalize on silver price fluctuations.
- Historic Gains: Silver prices have increased by 154.57% year-to-date in 2023, while leading silver mining stocks have failed to keep pace, indicating a potential undervaluation in the market that could present future investment opportunities.
See More
Americas Gold and Silver Corp. (USAS) Soars 43.36% to New 52-Week High
- Stock Surge: Americas Gold and Silver Corporation (USAS) surged 43.36% last week, reaching a new 52-week high, reflecting strong investor interest in mining stocks amid rising precious metal prices.
- Daily Performance: On Friday, USAS hit a peak price of $9.41 before closing at $9.29, up 9.55% from the previous day, indicating optimistic market expectations for its future performance.
- Silver Price Rally: With spot silver prices exceeding $103 and gold nearing $4,988—just $12 shy of $5,000—the overall rise in mining stocks has been significantly boosted.
- Production Milestone: In 2025, Americas Gold and Silver achieved a record silver production of 2.65 million ounces, a 52% increase, with its Cosala operations alone producing 1.19 million ounces, showcasing the company's robust production capabilities in a rising silver price environment.
See More
RUA GOLD Inc. Accelerates Development of New Zealand Gold-Antimony Project Targeting 300,000 Ounces Resource
- Accelerated Resource Development: RUA GOLD's latest drilling results at the Auld Creek project in New Zealand's Reefton Goldfield show 3.0m @ 21.27 g/t AuEq, successfully extending the deposit strike length by 250 meters to a total of 870 meters, with expectations to increase the resource to over 300,000 ounces, significantly enhancing the company's competitiveness in the global antimony market.
- Legislative Support: The company plans to leverage New Zealand's FAST TRACK legislation to expedite production permits for the Auld Creek project, aiming for approval within six months, which provides RUA GOLD with a strategic advantage in the global critical minerals supply chain.
- Strong Financial Position: With $14 million in cash on hand and a leadership team behind $11 billion in prior exits, RUA GOLD is well-positioned to ensure financial stability in resource development and market competition, effectively navigating market fluctuations.
- Optimistic Market Outlook: As global gold prices are projected to reach $5,055 per ounce by Q4 2026, RUA GOLD's projects will benefit from capital inflows into efficient platforms, driving the company's long-term growth potential in the gold and antimony sectors.
See More
Bright Minds Biosciences Launches $100 Million Public Offering
- Public Offering Impact: Bright Minds Biosciences Inc's announcement of a $100 million public offering led to a 2.3% drop in its pre-market share price to $91.03, reflecting market concerns over the new issuance and potentially impacting the company's short-term financing capabilities.
- Market Reaction: Following the public offering news, Bright Minds' stock price decline indicates cautious investor sentiment regarding the company's future prospects, which may lead to increased financing costs.
- Industry Dynamics: This offering has drawn attention within the biotech sector, particularly as investor acceptance of new issues diminishes in the current market environment, potentially affecting financing plans for other biotech firms.
- Competitive Pressure: The decline in Bright Minds' stock price coincides with fluctuations in shares of other companies like Cohen & Company and Gloo Holdings, highlighting overall market uncertainty in the biotech sector, which could undermine investor confidence across the industry.
See More
Sprott Silver Miners ETF Declines 2.3% with Americas Gold and Vizsla Silver Underperforming
- ETF Performance Decline: The Sprott Silver Miners & Physical Silver ETF fell approximately 2.3% in Wednesday afternoon trading, reflecting a weak sentiment towards silver mining stocks that could impact investor confidence.
- Individual Stock Weakness: Shares of Americas Gold and Silver dropped about 2.8%, while Vizsla Silver declined by approximately 1.6%, indicating the vulnerability of these companies in the current market environment, potentially leading to capital outflows.
- Market Trend Analysis: The overall decline of the ETF is linked to fluctuations in silver prices and investor risk aversion towards mining stocks, which may influence future investment decisions and capital allocation.
- Investor Focus: As silver mining stocks continue to struggle, investors may need to reassess their allocations within precious metal portfolios to mitigate potential market risks.
See More
Cybin Inc Launches $100 Million Equity Program, Shares Drop 6.6%
- Stock Decline: Cybin Inc's shares fell 6.6% to $8.00 in pre-market trading following the announcement of a $100 million at-the-market equity program with Cantor Fitzgerald, which may undermine investor confidence and complicate future fundraising efforts.
- Market Reaction: The drop in Cybin's stock price reflects investor concerns regarding the new financing plan, potentially impacting the company's capital operations and shareholder value moving forward.
- Industry Impact: Concurrently, other biotech firms like Corcept Therapeutics and NovaBay Pharmaceuticals also experienced stock declines, indicating a cautious sentiment across the biotech sector that could affect the overall fundraising environment.
- Investor Focus: The lukewarm market response to Cybin's financing initiative may prompt the company to reassess its capital structure and financing strategies to navigate current market challenges.
See More
Peter Schiff: Silver Mining Stocks Should Have Doubled in December
- Surge in Silver Prices: In December, silver prices surged by 35% to $76 per ounce, yet the Global X Silver Miners ETF only rose by 11%, indicating a significant disconnect that may lead investors to miss out on potential gains.
- Investor Denial: Schiff highlighted that silver mining stocks typically offer leveraged exposure to silver prices, but their underperformance amid a strong rally reflects a skeptical market attitude towards the sustainability of silver price increases.
- Attractive Investment Opportunity: Despite a 14% correction in silver prices, Schiff suggests that silver mining stocks are now better buys, potentially attracting investors looking to capitalize on silver price fluctuations.
- Historic Gains: Silver prices have increased by 154.57% year-to-date in 2023, while leading silver mining stocks have failed to keep pace, indicating a potential undervaluation in the market that could present future investment opportunities.
See More
